Recent Finacing
Recent Raise
Abilita Bio discovers and develops therapeutic antibodies targeting multi-span membrane proteins using its EMP platform and antibody discovery technologies, with four active programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Abilita Bio.
